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Abstract: Introduction: To investigate the association of mRNA expression of galectin-9 (Gal-9) and lactose 
maldigestion in obese children with different genotypes [13910 С>T polymorphism (rs4988235) of MCM6 
(minichromosome maintenance complex 6].  
Methods: The study involved 85 obese children (BMI>97 percentile) aged 6-18 years. The definition of 
MCM6 polymorphism (material for investigation-venous blood) and expression of Gal-9 mRNA (material 
for investigation-buccal epithelium) were determined by real-time polymerase chain reaction analysis 
using actin as a housekeeping gene ∆mRNA-Gal-9/mRNA actin, relation units-RU. Lactose maldigestion 
was studied using hydrogen breath testing. The first group of observations included 44 children with 
genotype C/C -13910, the second group consisted of 41 children with phenotypically identical genotypes C/T 
-13910, and T/T -13910, p>0.05.  
Results: Lactose maldigestion in children with genotype C/C -13910 averaged 36.05±4.73 ppm, in children 
with genotype C/T -13910 22.61±4.1 ppm (p<0.05), and with genotype T/T -13910 was absent (p<0.05). The 
average expression level of Gal-9 mRNA in children with genotype C/C -13910 was 564.6±35.8, in children 
with genotypes C/T and T/T -13910 61.02±15.8 RU, p<0.01. The lowest mean level of expression of Gal-9 
mRNA (42.47±13.4) was recorded in the subgroup of children with genotype C/C -13910 and lactose 
maldigestion (n=22). Whereas the largest mean level of expression of Gal-9 mRNA was recorded in the 
subgroup of children with the C/C -13910 genotype and without lactose maldigestion (n=22) 1086.73±51.2, 
p<0.01.  
Conclusions: The expression level of Gal-9 mRNA depends on lactose maldigestion in children with 
genotype C/C -13910.  
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INTRODUCTION Lactase deficiency (LD) (hypolactasia) can 
be congenital or acquired or lactase can be completely 
absent (alactasia). The lactase enzyme (lactase-phlorizin 
hydrolase, LCT, LPH, E.C.3.2.1.108) is expressed by 
differentiated enterocytes of the small intestine and is 
retained by glycocalyx in the apical part of the ciliated 
villus epithelium. 
The two intronic variations in the MCM6 
(minichromosome maintenance complex component 6) 
gene that are found to be associated with lactase 
persistence/non-persistence are located approximately 14  
kb and 22 kb upstream of the lactase gene (LCT, MIM 
603202, rs 4988235, chromosome 2q21) [1]. 
 
Single nucleotide polymorphisms (SNPs), due to the 
formation of specific alleles of genes, make an important 
contribution to phenotypic differences between people, 
including personality characteristics in the development of 
protective reactions, as well as predisposition to a number 
of diseases [2]. Human LCT gene polymorphisms are 
associated with the development of congenital lactase 
deficiency [3], and the SNP intronic regions of MCM6 are 
associated with lactase persistence [4]. The “wild” variant 
of the intronic regions sequence is associated with a 
gradual age-related suppression of the LCT gene 
expression and the development of primary adult-type 
hypolactasia, but the replacement of one nucleotide in 
certain places of the MCM6 enhancer region is 
accompanied by high expression of the LCT gene  
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throughout life. This phenomenon is demonstrated by in 
vitro experiments showing the strong binding of the 
transcription factor octamer-binding protein 1 (Oct-1) to 
the T−13910 variant, which can enhance the activity of the 
LCT gene promoter and increase the expression levels of 
LPH mRNA in the intestinal mucosa [5]. Given that the 
allele with MCM6 enhancer polymorphisms is dominant, 
both homo- and heterozygous individuals are 
characterized by lactase persistence. There are three 
genotypic variants of the SNP enhancer MCM6. The C/C-
13910 genotype is associated with a decrease in lactase 
production. Genotype C/T-13910 is associated with 
moderate retention of lactase production, and genotype 
T/T-13910 is associated with long-term retention of lactase 
production [1]. 
 
Galectin-9 (Gal-9) is a specific ligand for the phagocytic 
receptor of cellular apoptosis Tim-3 (T-cell 
immunoglobulin and the mucin 3 domain), a regulator of 
glucose and urate transport, and an acidophilic 
granulocyte chemoattractant [6-8]. Tim-3 receptor, after 
binding to Gal-9, induces apoptosis of Th1 cells [9]. Excess 
lactose, by binding to Gal-9, prevents the activation of Tim-
3, and plays a crucial role as an inhibitor of the activity of 
CD4+CD25+CD127-Treg-mediated suppression of immune 
Th1-Th17 responses [10]. Apoptosis of Th1 cells leads to a 
decrease in the production of pro-inflammatory cytokines 
such as IFN-γ, IL-2, IL-3, IL-12, TNF-α, TNF-β, and 
lymphotoxin, and provides an anti-inflammatory effect. 
Apoptosis of Th17 cells causes a decrease in the production 
of IL-6, IL-17A, IL-17F, IL-21, IL-22, IL-23, and TNF-β, 
causing inhibition of autoimmune reactions [11]. Thus, the 
Gal-9 protein is a key molecular regulator of the activity of 
the immune system, which produces its action by inducing 
apoptosis of Th1 and Th17 cells due to excitation of the 
calcium-calpain-caspase-1 cascade [10,12]. Recent studies 
have provided evidence that the Gal-9/Tim-3 signaling 
pathway may be an important pathogenetic mechanism 
for the development of obesity, insulin resistance, and 
type 2 diabetes mellitus [13-15]. The combination of 
excessive intake of lactose with food with a simultaneous 
age-related decrease in the activity of lactase increases the 
likelihood of immune-mediated human diseases, including 
obesity, the so-called disease of civilization. 
 
We investigated the association of mRNA expression of 
Gal-9 and lactose maldigestion in obese children with 
different variations in the intronic regions of MCM6 that 
have influence on LCT.  
 
MATERIAL AND METHODS  The study involved 85 obese 
children (54 boys and 31 girls with BMI>97 percentile) 
aged 6-18 years. 
 
Genotyping of the MCM6 enhancer of the LCT gene 
The study was conducted in the certified laboratory of 
Synevo-Ukraine. Genotyping for signs of allelic 
polymorphism of the MCM6: C-13910T of the LCT gene 
was begun with the extraction of genomic DNA from 
peripheral blood leukocytes using the AmliPrime DNA-
Sorb B reagent kit (No FSP 2012/4019) according to the 
manufacturer’s instructions (NextBio, Moscow, Russian 
Federation). Genotypes of the MCM6 enhancer of the LCT 
gene were detected using TaqMan® probes for 
polymerase chain reaction with real-time detection of the 
results (RT-PCR) on a CFX 96 amplifier (BioRad, Hercules, 
CA, USA). The technology includes the following steps: 1) 
amplification of the desired DNA sequence; 2) 
hybridization of amplicons with oligonucleotides labeled 
with fluorophores; 3) the formation of complementary 
and partially complementary duplexes; 4) melting 
(denaturation) of duplexes; and 5) detection of 
fluorescence with the subsequent construction and 
analysis of melting curves [16,17]. The PCR amplification 
was performed with the addition of up to 0.75 μl (20 ng) 
of isolated DNA, 20 μg of SNP Genotyping Assay Mix 
(Applied Biosystems, Foster City, CA, USA), and 2 ng of 
Universal PCR Master Mix buffer solution (Applied 
Biosystems, CA, USA). The SNP Genotyping Assay Mix 
consisted of specific forward (5՛- CTG CGC TGG CAA TAC 
AGA TAA G -3՛) and reverse (5՛- AAA TGC AAC CTA AGG 
AGG AGA GTT C-3՛) primers for amplifying and two 
TaqMan probes (each TaqMan probe contained a reporter 
dye at the 5՛-position). The VIC reporter dye was attached 
at the 5՛-position of the probe (ATA ATG TAG TCC CTG GCC 
T) to detect the T-allele. The 6-FAM reporter dye was 
attached at the 5՛-position of the probe (ATA ATG TAG CCC 
CTG GC) to detect the С-allele.  
 
The amplification program involved an initiation step that 
began with the previous activation of AmpliTaq Gold® DNA 
polymerase (Applied Biosystems, CA, USA) for 2 minutes at 
50°C and denaturation of double-stranded genomic DNA 
for 10 minutes at 95°C. The PCR included 40 cycles, each 
of which consisted of annealing or complementary primer 
attachment to single-stranded DNA targets and elongation  
AmpliTaq Gold® DNA polymerase of the second DNA 
strand of 15 sec at 92°C and 60 sec at 60°C. In the process 
of amplification, a simultaneous hybridization–
fluorescence detection was performed on samples using 
fluorescent probes on a DNA analyzer according to the  
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Assays-on-Demand protocols for SNP genotyping (No 
4331183, Applied Biosystems, CA, USA) to the application 
Allelic Discrimination of the ABI PRISM 7000 SDS Software 
(Applied Biosystems, CA, USA). 
 
Thus, three types of amplification products were 
determined:  
 
1. determination of the fluorescent signal only from the 
VIC dye—homozygote genotype T/T-13910,  
2. fluorescent signals from the VIC dye and 6-FAM dye—
heterozygote genotype C/T-13910, and 
3. fluorescent signal only from 6-FAM dye--homozygote 
genotype C/C-13910.  
To assess genotyping reproducibility, a random 10% 
selection of samples was re-genotyped with 100% 
concordance. 
 
Determination of the expression of Gal-9 of mRNA 
Study of the expression of Gal-9 mRNA from the buccal 
epithelium was conducted in a certified laboratory of the 
Department of General and Molecular Pathophysiology of 
the O.O. Bogomolets Institute of Physiology of the 
National Academy of Sciences of Ukraine using the RT-PCR 
method with reverse transcription according to TaqMan 
Gene Expression Assays protocol and included the 
following steps: 
1. Isolation of Gal-9 mRNA from the primary material 
(buccal epithelium). 
2. Preamplification (preparation of primers for mRNA). 
Mixed mRNA, 5X hexameric primer of arbitrary sequence 
SO142 Hexamer Random (Thermo Scientific, Carlsbad, CA, 
USA) and deionized water. Primary denaturation lasted 5 
minutes at a temperature of 70°C in the thermocycler 
GeneAmp PCR System 2700 (Applied Biosystems, CA, 
USA). 
3. Reverse transcription. Reverse transcription was 
performed using a hexamer primer using RevertAid 
Reverse Transcriptase (Thermo Scientific, CA, USA), 
selected mRNA, and reverse transcriptase. The resultant 
reverse transcription of single chain cloned DNA (cDNA) 
was used to quantify the expression of genes using PCR-RT 
using primers for the respective genes [TagMan Gene 
Expression Assay FAM (4448892) Assay ID 
Hs04190742_mH (LGALS9), and the TagMan β-Actin  
Control Kit Reagent (Applied Biosystems, CA, USA)]. 
Expression of genes has been standardized with respect to 
the expression of the β-actin gene as an endogenous 
control (one of the so-called Housekeeping genes).  
 
4. The amplification was carried out using the 7500 Fast 
Real-Time PCR System (Applied Biosystems, CA, USA) 
thermocycler for 42 minutes. Data analysis was performed 
using 7500 Fast Real-Time PCR Software. The amplification 
program began with pre-activation of AmpliTaq Gold® 
DNA polymerase (Applied Biosystems, CA, USA) for 10 
minutes at 95°C and included 45 cycles, each consisting of 
denaturation at 95°C (19 sec), primer attachment and 
elongation at 58°C (1 min). To control the specificity, a 
dissociation stage was carried out, with a sequential 
increase in temperature from 58°C to 95°C with a 
registration of the drop in the fluorescence intensity of 
double-stranded DNA complexes with SYBR Green. 
5. Data analysis was performed with 7500 Fast Real-Time 
PCR Software. The relative level of gene expression was 
determined using a generally accepted technique 
(expression level = 2ΔСt, where Ct is the threshold 
amplification cycle). 
 
Hydrogen breath test with lactose load (HBTLL) 
The concentration of hydrogen in exhaled air was 
determined by the Gastro + Gastrolyser gas analyzer of the 
British company Bedfont® Scientific Ltd in parts per million 
(ppm) with an accuracy of ± 1 ppm. Automatic data 
analysis was performed using GastroCHART software 
(Bedfont Scientific Ltd, Harrietsham, Maidstone, Kent, UK). 
Duration for HBTLL was 3 hours at intervals of 30 minutes. 
A test was considered positive when the level of hydrogen 
in exhaled air increased after 60 minutes by more than 20 
ppm compared to the basal level and clinical symptoms of 
lactase intolerance (abdominal pain, flatulence, and 
diarrhea) appeared on a visual-analogue scale for the next 
eight hours of observations [18]. 
 
Depending on the LCT genotyping data by RT-PCR, all 
children were divided into two groups: with the C/C -13910 
genotype, which is associated with adult-type LD (n=44, I 
group) and with phenotypically genotypes C/T -13910, and 
T/T -13910, associated with heterozygous and homozygous 
lactase persistence (n=41, II group). The first clinical group 
consisted of 27 boys (61.4%) and 17 girls (38.6%). The 
average age of the patients was 12.09±0.59 years. The 
second clinical group was represented by 27 boys (65.85%) 
and 14 girls (34.14%). The average age of the examined 
was 12.19±0.12 years (p> 0.05).  
 
Statistical analysis 
For statistical processing of research materials, the 
normality of the distribution of quantitative traits was 
checked according to the Shapiro-Wilk criterion. Data are  
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expressed as mean ± SEM. Intergroup comparisons of 
statistical characteristics were carried out taking into 
account the distribution law using parametric and 
nonparametric criteria. The reliability of differences in the 
mean values for unrelated samples was assessed by 
Student (t) and Mann-Whitney (U) criteria, for connected 
ones, by Student (T) and Wilcoxon (T), using Microsoft 
Excel (Office Home Business, USA) and STATISTICA 6.1 
software (StatSoftInc, Tulsa, OK, USA). The critical value of 
the level of statistical significance in testing all null 
hypotheses was taken to be 0.05 (5%). 
 
RESULTS  Genotype C/C -13910 was registered in 44 (51.8%), 
genotype C/T -13910 in 30 (35.3%), and genotype T/T in 11 
(12.9%) patients. Lactose maldigestion in children with 
genotype C/C -13910 averaged 36.05±4.73 ppm, in children 
with genotypes C/T -13910  22.61±4.1 ppm (p<0.05), and 
with genotype T/T -13910 was absent (p<0.05). The ratio of 
average values of hydrogen concentration in exhaled air 
under lactose loading in children with T/T-13910, C/T-13910, 
C/C-13910 genotypes corresponds to 1:17:27, respectively.  
 
The average expression level of Gal-9 mRNA in children 
with genotype C/C-13910, regardless of the level of lactose 
digestion, was 564.3±32.8 RU ΔmRNA Gal-9/mRNA actin. 
At a relatively preserved level of lactose digestion in 
individuals with the C/C-13910 genotype, overexpression of 
Gal-9 mRNA was 1086.73±52.6 RU ΔmRNA Gal-9/mRNA 
actin. The presence of clinically expressed lactose 
maldigestion in children with the C/C-13910 genotype was 
associated with a pronounced reduction of Gal-9 mRNA 
expression, 42.47±13.3 RU ΔmRNA Gal-9/mRNA actin, p 
<0.001. In children with the C/T and T/T-13910 genotypes, 
the expression level of Gal-9 mRNA was 61.04±15.3 RU 
ΔmRNA Gal-9/mRNA actin, p <0.01. 
 
The lowest mean level of expression of Gal-9 mRNA 
(42.47±13.4 RU ∆mRNA Gal-9/mRNA actin) was recorded 
in the subgroup of children with genotype C/C -13910 and 
lactose maldigestion (n=22). Whereas the largest mean 
level of expression of Gal-9 mRNA was recorded in the 
subgroup of children with the C/C -13910 and without lactose 
maldigestion (n=22) 1086.73±51.2 relation units ∆mRNA 
Gal-9/mRNA actin, p<0.01.  
 
DISCUSSION Studies in the Caucasian populations [7,19-
21] showed a high correlation between lactose digestion,  
intestinal lactase levels, and genetic tests in individuals 
with different SNP MCM6 genotypes. 
 
Previous studies have shown that administration of β-
lactose causes inflammation similar to the effects  
obtained in knocked out mice of the Lgals9 gene [1,22]. 
With an excessive concentration of lactose, the highest 
proliferative activity of mature cytotoxic CD8+T-
lymphocytes observed in the acute phase of the 
inflammatory process [23]. Lactose, binding to Gal-9, 
prevents the activation of Tim-3 and plays a decisive role 
in the trigger of Th1 and Th17-associated reactions. Under 
physiological conditions, Treg (CD4+CD25+CD127-) cells in 
vitro inhibit IFN-γ secretion (3.9-8.8 ng/ml, n=20; p=0.003) 
by Th1 and IL-17 cells (0.64-0.83 ng/ml, n=15; p=0.04) for 
Th17 cells. In the presence of lactose, Treg cells lose their 
ability to inhibit the secretion of IFN-γ and IL-17 (16.4 vs. 
3.99 ng/ml, n=20, p<0.0001 and 0.74 vs. 0.64 ng/ml, n=15, 
p=0.005, respectively) [10]. Thus, there is an increase in 
cellular pro-inflammatory processes, as well as the 
induction of autoimmune diseases and delayed 
hypersensitivity reactions that support chronic 
inflammation [24] and tumor processes [25,26]. 
 
However, our study first demonstrated the relationship 
between the level of Gal-9 expression and the genetically 
determined risk of insulin resistance due to the presence 
of an adult-type lactase deficiency. 
 
In children with the C/C-13910 genotype, the level of Gal-9 
mRNA expression depends on the level of lactose 
digestion. Decreased expression of Gal-9 mRNA due to 
mating with impaired lactase synthesis or the effect of 
lactose excess may underlie the pro-inflammatory 
response associated with insufficient activity of the 
inhibitory signal associated with Tim-3. In our opinion, a 
study of the expression of Gal-9 mRNA in children with the 
C/C-13910 genotype can serve as a marker for early diagnosis 
of the tendency of an unfavorable course of lactase 
deficiency (obesity, insulin resistance, type 2 diabetes 
mellitus). 
 
CONCLUSIONS In children with the C/C-13910 genotype, the 
expression level of Gal-9 mRNA depends on lactose 
maldigestion, which requires replacement therapy or a 
low-lactose diet. In our opinion, studies on the expression 
of Gal-9 mRNA in obese children with lactose maldigestion 
contribute to a more in-depth understanding of the 
persistence of compensatory mechanisms that ensure 
lactose hydrolysis than HBTLL. 
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